| 11001 | Attendance/disability/mobility allowance - Disability living allowance | Other sociodemographic factors | UKBB00000058 | 0.01 |
| 11002 | Average total household income before tax | Household | UKBB00000081 | 0.01 |
| 11003 | FCAR/LY96 ratio | GCST90314788 | 0.01 |
| 11004 | AMY2B levels | GCST90468299 | 0.01 |
| 11005 | ALPP levels | GCST90468286 | 0.01 |
| 11006 | Urine X-24798 levels in chronic kidney disease | GCST90266802 | 0.01 |
| 11007 | Fruit liking | GCST90094766 | 0.01 |
| 11008 | DAG1 levels | GCST90468943 | 0.01 |
| 11009 | FCRL5/LY96 ratio | GCST90314803 | 0.01 |
| 11010 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T459 | ECGA000459 | 0.01 |
| 11011 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T442 | ECGU000442 | 0.01 |
| 11012 | ATF6 levels | GCST90240816 | 0.01 |
| 11013 | Seborrhoeic dermatitis | FING00001282 | 0.01 |
| 11014 | CLPP levels | GCST90468785 | 0.01 |
| 11015 | DPP6/NELL2 ratio | GCST90314541 | 0.01 |
| 11016 | Chicken liking | GCST90094732 | 0.01 |
| 11017 | Insulin fold change during an oral glucose tolerance test (adjusted for BMI) | GCST90267567 | 0.01 |
| 11018 | NPDC1 levels | GCST90470069 | 0.01 |
| 11019 | Saturated fatty acid levels | GCST90092980 | 0.01 |
| 11020 | Number of self-reported non-cancer illnesses | Medical conditions | UKBB00000541 | 0.01 |
| 11021 | Frequency of walking for pleasure in last 4 weeks | Physical activity | UKBB00000271 | 0.01 |
| 11022 | Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers) | FING00001143 | 0.01 |
| 11023 | DOK2/GRAP2 ratio | GCST90314531 | 0.01 |
| 11024 | DTI autoptx MD fma tract | GCST90385230 | 0.01 |
| 11025 | F-capsicum liking (derived food-liking factor) | GCST90094726 | 0.01 |
| 11026 | Type 2 diabetes, definitions combined | FING00001382 | 0.01 |
| 11027 | Obesity | FING00000895 | 0.01 |
| 11028 | TCN2 levels | GCST90470820 | 0.01 |
| 11029 | Cholesteryl ester levels in large LDL | GCST90092858 | 0.01 |
| 11030 | MMP9 levels | GCST90469923 | 0.01 |
| 11031 | F-burn/spicy liking (derived food-liking factor) | GCST90094716 | 0.01 |
| 11032 | Thyroid stimulating hormone levels within normal range in pregnancy | GCST90435195 | 0.01 |
| 11033 | Glycine levels | GCST90497315 | 0.01 |
| 11034 | FOLR3 levels | GCST90469261 | 0.01 |
| 11035 | T1 FreeSurfer aseg Right-Caudate | GCST90384162 | 0.01 |
| 11036 | STX8 levels | GCST90470776 | 0.01 |
| 11037 | CA3 levels | GCST90468512 | 0.01 |
| 11038 | Occupation and workplace environment (confirmatory factor analysis Factor 5) | GCST90309340 | 0.01 |
| 11039 | KIR2DL3 levels | GCST90469685 | 0.01 |
| 11040 | Nasal polyp | FING00000858 | 0.01 |
| 11041 | Total free cholesterol levels | GCST90500063 | 0.01 |
| 11042 | CXADR/MME ratio | GCST90314329 | 0.01 |
| 11043 | BST2 levels | GCST90468475 | 0.01 |
| 11044 | Crohn's disease | GCST90475318 | 0.01 |
| 11045 | IL1R1/IL1RN ratio | GCST90315158 | 0.01 |
| 11046 | DBI/MESD ratio | GCST90314409 | 0.01 |
| 11047 | Job involved shift work | Employment history | UKBB00000382 | 0.01 |
| 11048 | ICD10 O60: Preterm labor and delivery | GCST90454242 | 0.01 |
| 11049 | Loneliness (weighted GWA) | GCST90267289 | 0.01 |
| 11050 | METAP2/PFKFB2 ratio | GCST90315431 | 0.01 |
| 11051 | RAB31 levels | GCST90087552 | 0.01 |
| 11052 | TCL1A/TNFRSF13C ratio | GCST90315912 | 0.01 |
| 11053 | Ulcerative colitis (strict) with PSC | FING00001389 | 0.01 |
| 11054 | hematocrit (mean, inv-norm transformed) | GCST90475341 | 0.01 |
| 11055 | Number of days/week of vigorous physical activity 10+ minutes | Physical activity | UKBB00000534 | 0.01 |
| 11056 | Hematocrit | GCST90018740 | 0.01 |
| 11057 | Diabetes (standard GWA) | GCST90267278 | 0.01 |
| 11058 | LDL cholesterol levels | GCST90092883 | 0.01 |
| 11059 | ADAM15 levels | GCST90468217 | 0.01 |
| 11060 | CETN3 levels | GCST90468722 | 0.01 |
| 11061 | IGLC2 levels | GCST90469536 | 0.01 |
| 11062 | CCN2/TACC3 ratio | GCST90313717 | 0.01 |
| 11063 | Operative procedures - No procedure performed | Summary Operations | UKBB00000584 | 0.01 |
| 11064 | PCOLCE levels | GCST90470175 | 0.01 |
| 11065 | CLC levels | GCST90468762 | 0.01 |
| 11066 | Chronic ulcer of skin, not elsewhere classified | FING00000300 | 0.01 |
| 11067 | Diseases of white blood cells (PheCode 288) | GCST90475812 | 0.01 |
| 11068 | Total lipid levels in large LDL | GCST90092862 | 0.01 |
| 11069 | Gestational diabetes mellitus | GCST90566419 | 0.01 |
| 11070 | EDAR/LAT2 ratio | GCST90314582 | 0.01 |
| 11071 | Pollock liking | GCST90094813 | 0.01 |
| 11072 | CSF1/IL10RB ratio | GCST90314284 | 0.01 |
| 11073 | SEZ6 levels | GCST90470608 | 0.01 |
| 11074 | Other symptoms of respiratory system (PheCode 512) | GCST90476039 | 0.01 |
| 11075 | REST UKBBICA NODEamps25 0009 | GCST90385492 | 0.01 |
| 11076 | REST UKBBICA NODEamps25 0021 | GCST90385504 | 0.01 |
| 11077 | Thyroid stimulating hormone levels | GCST90296333 | 0.01 |
| 11078 | CDKN2D/TACC3 ratio | GCST90313992 | 0.01 |
| 11079 | Water consumption (glasses per day) (UKB data field 1528) | GCST90132985 | 0.01 |
| 11080 | ERMAP levels | GCST90469147 | 0.01 |
| 11081 | Celiac disease (PheCode 557.1) | GCST90044158 | 0.01 |
| 11082 | PPP1R2/TACC3 ratio | GCST90315719 | 0.01 |
| 11083 | T1 FreeSurfer aseg rhCerebralWhiteMatterVol | GCST90384186 | 0.01 |
| 11084 | rfMRI connectivity (ICA25 edge 101) | GCST90004744 | 0.01 |
| 11085 | CD1C levels | GCST90468604 | 0.01 |
| 11086 | Other malignant neoplasms of skin | Melanoma and other malignant neoplasms of skin | UKBB00000613 | 0.01 |
| 11087 | FKBP5/MAP4K5 ratio | GCST90314843 | 0.01 |
| 11088 | Globe artichoke liking | GCST90094771 | 0.01 |
| 11089 | Fasting glucose | GCST90278628 | 0.01 |
| 11090 | Weight, inverse-rank normalized | FING00001447 | 0.01 |
| 11091 | Total lipid levels in LDL | GCST90092886 | 0.01 |
| 11092 | WFDC1 levels | GCST90471074 | 0.01 |
| 11093 | CEACAM5 levels | GCST90468696 | 0.01 |
| 11094 | Myasthenia gravis | GCST90432156 | 0.01 |
| 11095 | CPB1/CTRB1 ratio | GCST90314208 | 0.01 |
| 11096 | Strawberries liking | GCST90094849 | 0.01 |
| 11097 | Mean corpuscular hemoglobin concentration | GCST004605 | 0.01 |
| 11098 | IDP T1 FAST ROIs L cerebellum VIIIa | GCST90002578 | 0.01 |
| 11099 | lymphocyte (absolute count, maximum, inv-norm transformed) | GCST90475423 | 0.01 |
| 11100 | Use of hypnotics and sedatives | FING00001411 | 0.01 |
| 11101 | PCSK7 levels | GCST90470176 | 0.01 |
| 11102 | AK1 levels | GCST90468269 | 0.01 |
| 11103 | wg rh intensity-contrast cuneus | GCST90003831 | 0.01 |
| 11104 | ARSA/GUSB ratio | GCST90313355 | 0.01 |
| 11105 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T428 | ECGU000428 | 0.01 |
| 11106 | Type 1 diabetes (PheCode 250.1) | GCST90475661 | 0.01 |
| 11107 | HCLS1/LAT ratio | GCST90315041 | 0.01 |
| 11108 | MATN3 levels | GCST90469865 | 0.01 |
| 11109 | Main speciality of consultant (recoded) - Gastroenterology | Summary Administration | UKBB00000415 | 0.01 |
| 11110 | FGF21/LEP ratio | GCST90314810 | 0.01 |
| 11111 | Chronic airway obstruction (PheCode 496) | GCST90476027 | 0.01 |
| 11112 | RETN/RNASET2 ratio | GCST90315768 | 0.01 |
| 11113 | Disorders of skin appendages | FING00000460 | 0.01 |
| 11114 | CXCL5/SDC4 ratio | GCST90314353 | 0.01 |
| 11115 | CD59/PI3 ratio | GCST90313858 | 0.01 |
| 11116 | CRTAM/GZMA ratio | GCST90314275 | 0.01 |
| 11117 | FGF23 levels | GCST90469223 | 0.01 |
| 11118 | SEMA4C levels | GCST90470572 | 0.01 |
| 11119 | Neutrophils and lymphocytes in blood (confirmatory factor analysis Factor 35) | GCST90309369 | 0.01 |
| 11120 | Biological Sibling: Cancer, Skin | GCST90476369 | 0.01 |
| 11121 | Linoleic acid levels | GCST90502009 | 0.01 |
| 11122 | CSTB levels | GCST90012006 | 0.01 |
| 11123 | Operation code - appendicectomy | Operations | UKBB00000549 | 0.01 |
| 11124 | Left-hemisphere somatomotor network to left-hemisphere limbic network white-matter structural connectivity | GCST90302672 | 0.01 |
| 11125 | Bread type: White vs wholemeal/wholegrain and brown (UKB data field 1448) | GCST90132967 | 0.01 |
| 11126 | Ulcerative colitis (PheCode 555.2) | GCST90044155 | 0.01 |
| 11127 | CXCL10/CXCL11 ratio | GCST90314330 | 0.01 |
| 11128 | Other systemic involvement of connective tissue (FG) | FING00001116 | 0.01 |
| 11129 | Nonsuppurative otitis media | FING00000885 | 0.01 |
| 11130 | GUCA2A levels | GCST90469418 | 0.01 |
| 11131 | Principal component-derived dietary pattern 12 | GCST90133017 | 0.01 |
| 11132 | Lymphocyte count | GCST90002388 | 0.01 |
| 11133 | Volume of right paralaminar nucleus | GCST90475051 | 0.01 |
| 11134 | Ratio of saturated fatty acids to total fatty acids | GCST90092981 | 0.01 |
| 11135 | VAMP5 levels | GCST90471024 | 0.01 |
| 11136 | BTN2A1/SPINT2 ratio | GCST90313550 | 0.01 |
| 11137 | Hematocrit | GCST90002305 | 0.01 |
| 11138 | SIRT1 levels | GCST90470641 | 0.01 |
| 11139 | LY96/ST6GAL1 ratio | GCST90315348 | 0.01 |
| 11140 | SERPINA9 levels | GCST90470588 | 0.01 |
| 11141 | IPCEF1/SMAD1 ratio | GCST90315185 | 0.01 |
| 11142 | TNFRSF8 levels | GCST90470915 | 0.01 |
| 11143 | CALCOCO1/CASP3 ratio | GCST90313596 | 0.01 |
| 11144 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T448 | ECGU000448 | 0.01 |
| 11145 | IDP dMRI TBSS ISOVF Posterior thalamic radiation R | GCST90004505 | 0.01 |
| 11146 | AmygNuclei lh volume Lateral-nucleus | GCST90002648 | 0.01 |
| 11147 | Sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2) levels | GCST90200013 | 0.01 |
| 11148 | Aplastic anemia (PheCode 284) | GCST90475783 | 0.01 |
| 11149 | TNFRSF1A/TNFRSF1B ratio | GCST90315937 | 0.01 |
| 11150 | BMI and adiposity (confirmatory factor analysis Factor 7) | GCST90309342 | 0.01 |
| 11151 | Early onset COPD | FING00000485 | 0.01 |
| 11152 | Physical activity (Total log acceleration) | GCST90061408 | 0.01 |
| 11153 | DNMBP/WWP2 ratio | GCST90314522 | 0.01 |
| 11154 | Dermatitis | FING00000401 | 0.01 |
| 11155 | Pain in limb | FING00001138 | 0.01 |
| 11156 | Asthma (childhood onset) | GCST007800 | 0.01 |
| 11157 | ATXN10/PRTFDC1 ratio | GCST90313398 | 0.01 |
| 11158 | ThalamNuclei lh volume CM | GCST90002718 | 0.01 |
| 11159 | Brainstem global volume Midbrain | GCST90002767 | 0.01 |
| 11160 | MMP1/SERPINB6 ratio | GCST90315462 | 0.01 |
| 11161 | ABHD14B/CRADD ratio | GCST90313141 | 0.01 |
| 11162 | Cake icing liking | GCST90094723 | 0.01 |
| 11163 | CCL5/TACC3 ratio | GCST90313707 | 0.01 |
| 11164 | Lymphocyte count (UKB data field 30120) | GCST90468082 | 0.01 |
| 11165 | Respiratory disease (confirmatory factor analysis Factor 11) | GCST90309345 | 0.01 |
| 11166 | NEFL levels | GCST90470024 | 0.01 |
| 11167 | Raw vegetable consumption | GCST90132978 | 0.01 |
| 11168 | Principal component-derived dietary pattern 18 | GCST90133023 | 0.01 |
| 11169 | IDP dMRI ProbtrackX ICVF str r | GCST90004399 | 0.01 |
| 11170 | Skin cancer | GCST90475189 | 9.99e-03 |
| 11171 | Degree of unsaturation | GCST90502746 | 9.99e-03 |
| 11172 | Left-hemisphere salience/ventral attention network to hippocampus white-matter structural connectivity | GCST90302723 | 9.99e-03 |
| 11173 | Age first had sexual intercourse | Sexual factors | UKBB00000014 | 9.98e-03 |
| 11174 | T1 FreeSurfer aseg Left-Caudate | GCST90384144 | 9.98e-03 |
| 11175 | Seropositive rheumatoid arthritis, wide | FING00001298 | 9.98e-03 |
| 11176 | F-highly palatable foods liking (derived food-liking factor) | GCST90094785 | 9.97e-03 |
| 11177 | Acceptance of an invitation to wear a physical activity monitor | GCST90012791 | 9.97e-03 |
| 11178 | Frailty index | GCST90020053 | 9.97e-03 |
| 11179 | EGF/MPIG6B ratio | GCST90314611 | 9.96e-03 |
| 11180 | Treatment/medication code - omeprazole | Medications | UKBB00000852 | 9.96e-03 |
| 11181 | Own or rent accommodation lived in - Own outright (by you or someone in your household) | Household | UKBB00000623 | 9.94e-03 |
| 11182 | PLA2G15 levels | GCST90470245 | 9.94e-03 |
| 11183 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T484 | ECGA000484 | 9.94e-03 |
| 11184 | Total fatty acid levels | GCST90092987 | 9.94e-03 |
| 11185 | CD74/TIMD4 ratio | GCST90313896 | 9.94e-03 |
| 11186 | EDAR/TMSB10 ratio | GCST90314590 | 9.91e-03 |
| 11187 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T220 | ECGA000220 | 9.90e-03 |
| 11188 | Lichen sclerosus et atrophicus | FING00000723 | 9.87e-03 |
| 11189 | TSC1 levels | GCST90470972 | 9.87e-03 |
| 11190 | Immature fraction of reticulocytes | GCST004628 | 9.87e-03 |
| 11191 | CREG1/GUSB ratio | GCST90314249 | 9.87e-03 |
| 11192 | EDAR/TACC3 ratio | GCST90314589 | 9.86e-03 |
| 11193 | FAM3B/GUCA2A ratio | GCST90314779 | 9.86e-03 |
| 11194 | Beans liking | GCST90094699 | 9.85e-03 |
| 11195 | BTN2A1/IFNGR1 ratio | GCST90313543 | 9.84e-03 |
| 11196 | Clonal hematopoiesis (large clone) | GCST90102621 | 9.83e-03 |
| 11197 | EBAG9/MITD1 ratio | GCST90314566 | 9.83e-03 |
| 11198 | MAVS/MED18 ratio | GCST90315389 | 9.83e-03 |
| 11199 | Obesity, other/unspecified | FING00000898 | 9.82e-03 |
| 11200 | CD27/NBL1 ratio | GCST90313774 | 9.81e-03 |
| 11201 | F-fatty/dairy food liking (derived food-liking factor) | GCST90094760 | 9.81e-03 |
| 11202 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T449 | ECGU000449 | 9.80e-03 |
| 11203 | Number of fluid intelligence questions attempted within time limit | Fluid intelligence / reasoning | UKBB00000537 | 9.80e-03 |
| 11204 | HippSubfield lh volume Hippocampal-tail | GCST90002668 | 9.79e-03 |
| 11205 | PEAR1/SPINT2 ratio | GCST90315644 | 9.79e-03 |
| 11206 | INSR levels | GCST90469623 | 9.75e-03 |
| 11207 | Mineral and other dietary supplements - Fish oil (including cod liver oil) | Medication | UKBB00000472 | 9.74e-03 |
| 11208 | CD19 on IgD- CD38- B cell | GCST90001733 | 9.74e-03 |
| 11209 | Fasting blood glucose | GCST005186 | 9.73e-03 |
| 11210 | Poultry consumption | GCST90132996 | 9.73e-03 |
| 11211 | CTRB1/PLA2G1B ratio | GCST90314307 | 9.71e-03 |
| 11212 | Cholesteryl esters to total lipids ratio in small VLDL | GCST90092971 | 9.69e-03 |
| 11213 | LGALS4/TIE1 ratio | GCST90315316 | 9.68e-03 |
| 11214 | CPB1/REG1B ratio | GCST90314213 | 9.67e-03 |
| 11215 | Hemorrhagic fever with renal syndrome | GCST90454190 | 9.62e-03 |
| 11216 | Alzheimer's disease | GCST90027158 | 9.62e-03 |
| 11217 | Frailty (Factor 2 - Unhealthy Lifestyle) | GCST90624048 | 9.60e-03 |
| 11218 | IL15/KLRD1 ratio | GCST90315149 | 9.58e-03 |
| 11219 | Type 2 diabetes | GCST90086071 | 9.58e-03 |
| 11220 | ART3/RGMB ratio | GCST90313363 | 9.55e-03 |
| 11221 | Diseases of liver | FING00000425 | 9.55e-03 |
| 11222 | STC2 levels | GCST90470762 | 9.54e-03 |
| 11223 | SLAMF1 levels | GCST90470649 | 9.51e-03 |
| 11224 | Reason for reducing amount of alcohol drunk - Other reason | Alcohol | UKBB00000735 | 9.51e-03 |
| 11225 | CXCL5/SERPINE1 ratio | GCST90314354 | 9.50e-03 |
| 11226 | Systemic connective tissue disorders | FING00001350 | 9.49e-03 |
| 11227 | Insomnia complaints | GCST006488 | 9.48e-03 |
| 11228 | CDH15 levels | GCST90468668 | 9.41e-03 |
| 11229 | Principal component-derived dietary pattern 3 | GCST90133008 | 9.41e-03 |
| 11230 | SEMA4D/TREML2 ratio | GCST90315823 | 9.40e-03 |
| 11231 | CD14 levels | GCST90468598 | 9.39e-03 |
| 11232 | Cancer of prostate (PheCode 185) | GCST90475591 | 9.38e-03 |
| 11233 | RETN levels | GCST90012034 | 9.35e-03 |
| 11234 | Basal cell carcinoma (MTAG) | GCST90137411 | 9.34e-03 |
| 11235 | GPR15L levels | GCST90469396 | 9.34e-03 |
| 11236 | CDH1/CDH17 ratio | GCST90313945 | 9.32e-03 |
| 11237 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T441 | ECGU000441 | 9.31e-03 |
| 11238 | DTI autoptx L1 ptr r tract | GCST90385159 | 9.30e-03 |
| 11239 | wg lh intensity-contrast lingual | GCST90003804 | 9.30e-03 |
| 11240 | Gastritis and duodenitis | digestive | UKBB00000277 | 9.29e-03 |
| 11241 | Bread type: White (UKB data field 1448_1) | GCST90132964 | 9.27e-03 |
| 11242 | All influenza | FING00000064 | 9.25e-03 |
| 11243 | Ulcerative colitis | GCST90475322 | 9.24e-03 |
| 11244 | Melanoma in situ (controls excluding all cancers) | FING00000803 | 9.22e-03 |
| 11245 | CCL4 levels | GCST004433 | 9.20e-03 |
| 11246 | Time spend outdoors in summer | Sun exposure | UKBB00000817 | 9.19e-03 |
| 11247 | DBNL/HSPA1A ratio | GCST90314418 | 9.18e-03 |
| 11248 | Physical activity (Total log acceleration 12am-2am) | GCST90061409 | 9.17e-03 |
| 11249 | Cancer of prostate (PheCode 185) | GCST90041853 | 9.17e-03 |
| 11250 | ANGPT1/CCN2 ratio | GCST90313261 | 9.14e-03 |
| 11251 | IDP dMRI TBSS L1 Posterior limb of internal capsule L | GCST90004094 | 9.13e-03 |
| 11252 | TGFB1 levels | GCST90274818 | 9.10e-03 |
| 11253 | Non-cancer illness code, self-reported - eczema/dermatitis | Medical conditions | UKBB00000509 | 9.09e-03 |
| 11254 | Illnesses of siblings - Diabetes | Family history | UKBB00000350 | 9.08e-03 |
| 11255 | CD69/EDAR ratio | GCST90313875 | 9.08e-03 |
| 11256 | Ectropion or entropion (PheCode 374.1) | GCST90475891 | 9.07e-03 |
| 11257 | MAP4K5/STAMBP ratio | GCST90315382 | 9.06e-03 |
| 11258 | CXCL10 levels | GCST90274780 | 9.06e-03 |
| 11259 | Illness, injury, bereavement, stress in last 2 years - None of the above | Mental health | UKBB00000339 | 9.05e-03 |
| 11260 | mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed) | GCST90475452 | 9.05e-03 |
| 11261 | Melanomas of skin (PheCode 172.11) | GCST90475578 | 9.03e-03 |
| 11262 | FOXO1/IRAK4 ratio | GCST90314870 | 9.03e-03 |
| 11263 | Oxalate (ethanedioate) levels | GCST90199672 | 8.99e-03 |
| 11264 | Erythematosquamous dermatosis (PheCode 690) | GCST90476170 | 8.98e-03 |
| 11265 | Bronchitis | FING00000228 | 8.97e-03 |
| 11266 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54) | GCST90320617 | 8.96e-03 |
| 11267 | CRADD/FKBP4 ratio | GCST90314238 | 8.96e-03 |
| 11268 | CD207 levels | GCST90468607 | 8.96e-03 |
| 11269 | Severe, life-threatening illness (confirmatory factor analysis Factor 20) | GCST90309354 | 8.96e-03 |
| 11270 | Ceramide (d18:1/24:0) levels | GCST90024046 | 8.94e-03 |
| 11271 | ITIH3 levels | GCST90469650 | 8.93e-03 |
| 11272 | PTPRF/SDC1 ratio | GCST90315752 | 8.93e-03 |
| 11273 | Pain type(s) experienced in last month - Pain all over the body | Pain | UKBB00000632 | 8.93e-03 |
| 11274 | Diseases of middle ear and mastoid | FING00000427 | 8.91e-03 |
| 11275 | Age at first birth | GCST90000050 | 8.89e-03 |
| 11276 | BA-exvivo rh area BA4p | GCST90003226 | 8.87e-03 |
| 11277 | KIFBP/LYN ratio | GCST90315246 | 8.86e-03 |
| 11278 | Prostate cancer | GCST90274714 | 8.86e-03 |
| 11279 | Cardiometabolic multimorbidity | GCST90274723 | 8.86e-03 |
| 11280 | Triglycerides to total lipids ratio in chylomicrons and extremely large VLDL | GCST90093051 | 8.85e-03 |
| 11281 | CHI3L1/PRSS8 ratio | GCST90314044 | 8.83e-03 |
| 11282 | TNFSF11 levels | GCST90274844 | 8.83e-03 |
| 11283 | HS6ST2 levels | GCST90469480 | 8.82e-03 |
| 11284 | Alcohol liking | GCST90094688 | 8.78e-03 |
| 11285 | LAIR1 levels | GCST90469728 | 8.77e-03 |
| 11286 | CD300C/NBL1 ratio | GCST90313792 | 8.76e-03 |
| 11287 | CRLF1 levels | GCST90468868 | 8.75e-03 |
| 11288 | Coffee intake | Diet | UKBB00000138 | 8.74e-03 |
| 11289 | FAM177A1 levels | GCST90242458 | 8.73e-03 |
| 11290 | PAEP levels | GCST90470144 | 8.72e-03 |
| 11291 | Skin luminance | GCST90320257 | 8.71e-03 |
| 11292 | CDKN1A/YES1 ratio | GCST90313980 | 8.71e-03 |
| 11293 | Personal history of allergy to drugs, medicaments and biologocal substances | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000641 | 8.71e-03 |
| 11294 | CRYGD levels | GCST90468876 | 8.70e-03 |
| 11295 | Nonspecific chest pain | circulatory system | UKBB00000527 | 8.70e-03 |
| 11296 | LGALS4/PCDH17 ratio | GCST90315315 | 8.67e-03 |
| 11297 | Mean corpuscular hemoglobin concentration | GCST90002328 | 8.67e-03 |
| 11298 | IDP T1 SIENAX grey normalised volume | GCST90002430 | 8.66e-03 |
| 11299 | LBR/LGALS8 ratio | GCST90315294 | 8.66e-03 |
| 11300 | Hyperthyroidism | GCST90319319 | 8.64e-03 |
| 11301 | Water intake | Diet | UKBB00000906 | 8.61e-03 |
| 11302 | CFHR2 levels | GCST90468726 | 8.60e-03 |
| 11303 | Usual side of head for mobile phone use - Left | Electronic device use | UKBB00000889 | 8.59e-03 |
| 11304 | Handedness (confirmatory factor analysis Factor 36) | GCST90309370 | 8.58e-03 |
| 11305 | T1 FreeSurfer a2009s lh S postcentral area | GCST90384734 | 8.57e-03 |
| 11306 | Benign neoplasm of skin (PheCode 216) | GCST90475620 | 8.56e-03 |
| 11307 | Prevotella sp000434975 abundance in stool | GCST90032518 | 8.56e-03 |
| 11308 | Creatinine levels (UKB data field 23478) | GCST90269575 | 8.55e-03 |
| 11309 | AXIN1/SRPK2 ratio | GCST90313417 | 8.53e-03 |
| 11310 | eosinophil (absolute count, mean, inv-norm transformed) | GCST90475291 | 8.52e-03 |
| 11311 | Percentage of fucosylation of monogalactosylated structures in total neutral plasma glycans (GP74) | GCST90668518 | 8.51e-03 |
| 11312 | Sources of admission to hospital (recoded) - Usual Place of residence | Summary Administration | UKBB00000786 | 8.49e-03 |
| 11313 | Psoriatic arthritis vs Cutaneous psoriasis | GCST90243957 | 8.49e-03 |
| 11314 | Multiple myeloma and malignant plasma cell neoplasms (controls excluding all cancers) | FING00000843 | 8.49e-03 |
| 11315 | Attendance/disability/mobility allowance - None of the above | Other sociodemographic factors | UKBB00000059 | 8.49e-03 |
| 11316 | MYOM2 levels | GCST90469985 | 8.47e-03 |
| 11317 | Treatment/medication code - aspirin | Medications | UKBB00000841 | 8.47e-03 |
| 11318 | Phosphatidylethanolamine (18:0_18:1) levels | GCST90024977 | 8.46e-03 |
| 11319 | Weight | GCST90018729 | 8.45e-03 |
| 11320 | sodium (minimum, inv-norm transformed) | GCST90476397 | 8.43e-03 |
| 11321 | ITGB5/SIAE ratio | GCST90315234 | 8.43e-03 |
| 11322 | IDP dMRI ProbtrackX ISOVF ifo r | GCST90004538 | 8.42e-03 |
| 11323 | Eosinophill count | Blood count | UKBB00000206 | 8.41e-03 |
| 11324 | CST3/IL18BP ratio | GCST90314294 | 8.41e-03 |
| 11325 | CDKN1A/HBEGF ratio | GCST90313972 | 8.41e-03 |
| 11326 | Hypothyroidism, drug reimbursement | FING00000655 | 8.40e-03 |
| 11327 | CXCL3/CXCL5 ratio | GCST90314344 | 8.38e-03 |
| 11328 | HSIL lesion of the cervix uteri, vagina or vulva | FING00000625 | 8.38e-03 |
| 11329 | BSG levels | GCST90468472 | 8.37e-03 |
| 11330 | BLVRB/CA1 ratio | GCST90313521 | 8.35e-03 |
| 11331 | Platelet count (UKB data field 30080) | GCST90468095 | 8.35e-03 |
| 11332 | Platelet count | GCST004603 | 8.35e-03 |
| 11333 | Total Dihexosylceramide levels | GCST90025193 | 8.33e-03 |
| 11334 | CRYBB1 levels | GCST90468874 | 8.31e-03 |
| 11335 | Fluid intelligence score decline (difference score) | GCST90565862 | 8.28e-03 |
| 11336 | CD84/F2R ratio | GCST90313912 | 8.28e-03 |
| 11337 | IDP dMRI TBSS OD Cerebral peduncle R | GCST90004416 | 8.28e-03 |
| 11338 | Allergic asthma (mode) | FING00000066 | 8.28e-03 |
| 11339 | CRADD/DARS1 ratio | GCST90314234 | 8.27e-03 |
| 11340 | CFC1 levels | GCST90468724 | 8.27e-03 |
| 11341 | CCBL2 levels | GCST90241722 | 8.25e-03 |
| 11342 | ATOX1/TMSB10 ratio | GCST90313377 | 8.24e-03 |
| 11343 | Bread type: Wholemeal or wholegrain (UKB data field 1448_3) | GCST90132966 | 8.23e-03 |
| 11344 | Moderate to vigorous physical activity duration | GCST90061422 | 8.23e-03 |
| 11345 | DKK1/SDC4 ratio | GCST90314479 | 8.22e-03 |
| 11346 | White blood cell count | GCST90018758 | 8.22e-03 |
| 11347 | TNFRSF1B levels | GCST90470911 | 8.22e-03 |
| 11348 | Gastroesophageal reflux disease | GCST90000514 | 8.18e-03 |
| 11349 | Other non-epithelial cancer of skin | neoplasms | UKBB00000615 | 8.16e-03 |
| 11350 | HGFAC levels | GCST90469448 | 8.15e-03 |
| 11351 | CPA1/PLA2G1B ratio | GCST90314205 | 8.14e-03 |
| 11352 | DTI autoptx L3 ptr r tract | GCST90385213 | 8.14e-03 |
| 11353 | Leisure/social activities - Other group activity | Social support | UKBB00000400 | 8.14e-03 |
| 11354 | Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers) | FING00000846 | 8.13e-03 |
| 11355 | Sensorineural hearing loss | FING00001291 | 8.13e-03 |
| 11356 | FKBP4/RWDD1 ratio | GCST90314840 | 8.12e-03 |
| 11357 | Gastritis and duodenitis | Diseases of oesophagus, stomach and duodenum | UKBB00000278 | 8.11e-03 |
| 11358 | aparc-DKTatlas rh volume precuneus | GCST90002916 | 8.11e-03 |
| 11359 | KIF22 levels | GCST90469682 | 8.10e-03 |
| 11360 | SIGLEC10 levels | GCST90470630 | 8.10e-03 |
| 11361 | DTI TBSS L1 Posterior limb of internal capsule R | GCST90384446 | 8.09e-03 |
| 11362 | Hypothyroidism | GCST90018642 | 8.09e-03 |
| 11363 | CALCOCO1/CASP8 ratio | GCST90313597 | 8.05e-03 |
| 11364 | Leisure screen time | GCST90104339 | 8.04e-03 |
| 11365 | CCL4 levels | GCST90468583 | 8.03e-03 |
| 11366 | PYY levels | GCST90470398 | 8.03e-03 |
| 11367 | TIA1/USP8 ratio | GCST90315920 | 8.02e-03 |
| 11368 | PARP1/TCL1A ratio | GCST90315602 | 8.00e-03 |
| 11369 | Body fat rate | GCST90278619 | 7.99e-03 |
| 11370 | IL22RA2 levels | GCST90090699 | 7.98e-03 |
| 11371 | Aniseed liking | GCST90094689 | 7.98e-03 |
| 11372 | Left-hemisphere somatomotor network to left-hemisphere control network white-matter structural connectivity | GCST90302673 | 7.93e-03 |
| 11373 | SCN4B levels | GCST90470551 | 7.91e-03 |
| 11374 | ICAM2/SELE ratio | GCST90315120 | 7.91e-03 |
| 11375 | Asthma | GCST90468112 | 7.91e-03 |
| 11376 | PDGFB/SNAP29 ratio | GCST90315627 | 7.90e-03 |
| 11377 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T440 | ECGU000440 | 7.90e-03 |
| 11378 | Age hay fever, rhinitis or eczema diagnosed | Medical conditions | UKBB00000015 | 7.89e-03 |
| 11379 | AARSD1/PIK3AP1 ratio | GCST90313129 | 7.88e-03 |
| 11380 | ITGB1BP2/USP8 ratio | GCST90315223 | 7.88e-03 |
| 11381 | Migraine with aura and triptan purchases | FING00000820 | 7.86e-03 |
| 11382 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T467 | ECGA000467 | 7.85e-03 |
| 11383 | CNPY4/MESD ratio | GCST90314152 | 7.85e-03 |
| 11384 | TOP1 levels | GCST90470933 | 7.84e-03 |
| 11385 | HAVCR2 levels | GCST90469432 | 7.83e-03 |
| 11386 | Papulosquamous disorders | FING00001144 | 7.83e-03 |
| 11387 | Mucosal proctocolitis | FING00000841 | 7.82e-03 |
| 11388 | Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 7.99_210.09) | GCST90291312 | 7.82e-03 |
| 11389 | Scar conditions and fibrosis of skin (PheCode 701.2) | GCST90476198 | 7.81e-03 |
| 11390 | 1-stearoyl-GPE (18:0) levels | GCST90199772 | 7.80e-03 |
| 11391 | Waist circumference | GCST90278648 | 7.80e-03 |
| 11392 | EPHB6 levels | GCST90469133 | 7.80e-03 |
| 11393 | CD164/LGMN ratio | GCST90313741 | 7.80e-03 |
| 11394 | Mean corpuscular hemoglobin concentration | GCST90002391 | 7.80e-03 |
| 11395 | CD27/DLL1 ratio | GCST90313771 | 7.78e-03 |
| 11396 | Sicca syndrome [Sjögren] | FING00001304 | 7.77e-03 |
| 11397 | Obesity due to excess calories | FING00000896 | 7.75e-03 |
| 11398 | FXN/METAP1D ratio | GCST90314897 | 7.74e-03 |
| 11399 | GUCA2A/LGALS4 ratio | GCST90314998 | 7.73e-03 |
| 11400 | Continuous positive airway pressure | FING00000349 | 7.72e-03 |
| 11401 | CLEC4G/SEMA3F ratio | GCST90314123 | 7.69e-03 |
| 11402 | SEMA4D levels | GCST90470573 | 7.67e-03 |
| 11403 | Lymphoid neoplasms (B-cell phenocluster) | GCST90624736 | 7.67e-03 |
| 11404 | Potassium in urine | Urine assays | UKBB00000655 | 7.66e-03 |
| 11405 | Takes medication for asthma? | GCST90475260 | 7.65e-03 |
| 11406 | Educational attainment | GCST003496 | 7.64e-03 |
| 11407 | Eosinophil count | GCST90018733 | 7.64e-03 |
| 11408 | T1 FreeSurfer BA rh BA3a exvivo thickness | GCST90385563 | 7.64e-03 |
| 11409 | Type 1 diabetes, definitions combined | FING00001380 | 7.63e-03 |
| 11410 | SERPINA7 levels | GCST90470587 | 7.62e-03 |
| 11411 | EDAR/TREML2 ratio | GCST90314592 | 7.61e-03 |
| 11412 | EDAR/PSRC1 ratio | GCST90314584 | 7.61e-03 |
| 11413 | Takes medication for Skin condition (ex. Eczema, Psoriasis)? | GCST90475275 | 7.61e-03 |
| 11414 | BTN2A1 levels | GCST90468480 | 7.60e-03 |
| 11415 | Free Cholesterol to Total Lipids in Small HDL percentage | GCST90499431 | 7.60e-03 |
| 11416 | DTI TBSS MO Medial lemniscus R | GCST90384628 | 7.59e-03 |
| 11417 | Chest pain or discomfort | Chest pain | UKBB00000128 | 7.59e-03 |
| 11418 | Ectopic pregnancy | FING00000487 | 7.59e-03 |
| 11419 | ERBIN/LYN ratio | GCST90314694 | 7.58e-03 |
| 11420 | Lymphocyte count | GCST004627 | 7.57e-03 |
| 11421 | ICAM4 levels | GCST90469501 | 7.56e-03 |
| 11422 | Blood cell traits latent factor 12 (red cell) | GCST90559254 | 7.56e-03 |
| 11423 | CDH17/PECAM1 ratio | GCST90313942 | 7.56e-03 |
| 11424 | CD84/SDC4 ratio | GCST90313916 | 7.56e-03 |
| 11425 | Multiple myeloma | GCST90624747 | 7.55e-03 |
| 11426 | Prurigo nodularis | FING00001220 | 7.54e-03 |
| 11427 | Bundle branch block (PheCode 426.3) | GCST90475956 | 7.52e-03 |
| 11428 | KLRB1 levels | GCST90469709 | 7.52e-03 |
| 11429 | CST3/CTSZ ratio | GCST90314290 | 7.51e-03 |
| 11430 | Ulcerative colitis | GCST004133 | 7.51e-03 |
| 11431 | Lymphoid neoplasms (drug group 1 phenocluster) | GCST90624740 | 7.50e-03 |
| 11432 | LIPF levels | GCST90469780 | 7.48e-03 |
| 11433 | Lymphocyte count | Blood count | UKBB00000411 | 7.46e-03 |
| 11434 | Urinary incontinence (PheCode 599.4) | GCST90476152 | 7.42e-03 |
| 11435 | DCTN6/TDRKH ratio | GCST90314436 | 7.42e-03 |
| 11436 | Free cholesterol levels in very large HDL | GCST90132680 | 7.41e-03 |
| 11437 | Saturated fatty acids to total fatty acids percentage (UKB data field 23455) | GCST90269552 | 7.40e-03 |
| 11438 | CCL17/GRK5 ratio | GCST90313687 | 7.39e-03 |
| 11439 | SDC4/SERPINE1 ratio | GCST90315819 | 7.39e-03 |
| 11440 | CSF2 levels | GCST90468884 | 7.39e-03 |
| 11441 | CTSS levels | GCST90468916 | 7.37e-03 |
| 11442 | TXNDC15 levels | GCST90470990 | 7.37e-03 |
| 11443 | Types of transport used (excluding work) - Walk | Physical activity | UKBB00000879 | 7.37e-03 |
| 11444 | Other Crohn's disease | FING00000992 | 7.36e-03 |
| 11445 | rfMRI connectivity ICA-features 1 | GCST90006339 | 7.34e-03 |
| 11446 | EDAR/EGF ratio | GCST90314573 | 7.34e-03 |
| 11447 | Cholelithiasis and cholecystitis | digestive | UKBB00000133 | 7.31e-03 |
| 11448 | CA4/TNFSF12 ratio | GCST90313589 | 7.29e-03 |
| 11449 | F2R/GP6 ratio | GCST90314730 | 7.29e-03 |
| 11450 | ATF6 levels | GCST90617260 | 7.28e-03 |
| 11451 | Plasma sphingomyelin (d18:1/25:0, d19:0/24:1, d20:1/23:0, d19:1/24:0)* levels in chronic kidney disease | GCST90265971 | 7.28e-03 |
| 11452 | CA4/FOLR2 ratio | GCST90313585 | 7.26e-03 |
| 11453 | Glycine levels | GCST007638 | 7.26e-03 |
| 11454 | DTI TBSS L3 Anterior limb of internal capsule R | GCST90384540 | 7.25e-03 |
| 11455 | KLK14 levels | GCST90469700 | 7.24e-03 |
| 11456 | Intended management of patient (recoded) - No overnight hospital stay | Summary Administration | UKBB00000366 | 7.23e-03 |
| 11457 | Asthma | GCST90476024 | 7.22e-03 |
| 11458 | Pain (limb, back, neck, head abdominally) | FING00001135 | 7.22e-03 |
| 11459 | CA2/CA3 ratio | GCST90313576 | 7.21e-03 |
| 11460 | Other functional intestinal disorders | FING00001052 | 7.20e-03 |
| 11461 | Other and unspecified nerve root and plexus disorders, also in other diseases | FING00000944 | 7.20e-03 |
| 11462 | Hypo-osmolality and hyponatraemia | FING00000648 | 7.18e-03 |
| 11463 | Birth year infant mortality rates | GCST90095047 | 7.18e-03 |
| 11464 | ICD10 D25: Leiomyoma of uterus | GCST90454204 | 7.17e-03 |
| 11465 | UMOD levels | GCST90471009 | 7.16e-03 |
| 11466 | EFHD1 levels | GCST90469079 | 7.16e-03 |
| 11467 | CD79B/ICAM3 ratio | GCST90313901 | 7.15e-03 |
| 11468 | Beef/steak liking | GCST90094700 | 7.14e-03 |
| 11469 | CAPS levels | GCST90468539 | 7.14e-03 |
| 11470 | CALCOCO1/PFKFB2 ratio | GCST90313608 | 7.13e-03 |
| 11471 | Pregnenolone sulfate levels | GCST90199873 | 7.13e-03 |
| 11472 | Hypercalcemia (PheCode 275.6) | GCST90475748 | 7.12e-03 |
| 11473 | Single spontaneous delivery | FING00001307 | 7.12e-03 |
| 11474 | Atrial fibrillation and flutter (PheCode 427.2) | GCST90043977 | 7.12e-03 |
| 11475 | DTI TBSS L1 Anterior corona radiata R | GCST90384450 | 7.10e-03 |
| 11476 | Sodium (mean, inv-norm transformed) | GCST90476395 | 7.09e-03 |
| 11477 | CPA2 levels | GCST90468837 | 7.08e-03 |
| 11478 | QSOX1 levels | GCST90470402 | 7.06e-03 |
| 11479 | Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - None of the above | Medical conditions | UKBB00000101 | 7.05e-03 |
| 11480 | ITGA6/THPO ratio | GCST90315208 | 7.04e-03 |
| 11481 | Second line medication for Crohn's disease | FING00001284 | 7.03e-03 |
| 11482 | PDZK1 levels | GCST90470203 | 7.02e-03 |
| 11483 | ENO2/ITGB1BP2 ratio | GCST90314661 | 7.02e-03 |
| 11484 | TSPAN1 levels | GCST90470978 | 7.00e-03 |
| 11485 | DNAJA2/HCLS1 ratio | GCST90314502 | 6.99e-03 |
| 11486 | PADI4 levels | GCST90470143 | 6.99e-03 |
| 11487 | Myocardial fractal dimension (slice 2) | GCST90000288 | 6.97e-03 |
| 11488 | CSNK1D levels | GCST90468888 | 6.97e-03 |
| 11489 | LEP levels | GCST90469757 | 6.95e-03 |
| 11490 | REG3A levels | GCST90470449 | 6.95e-03 |
| 11491 | Volume of left medial nucleus | GCST90474976 | 6.95e-03 |
| 11492 | MGLL/MITD1 ratio | GCST90315436 | 6.92e-03 |
| 11493 | Gamma-CEHC glucuronide levels | GCST90199941 | 6.90e-03 |
| 11494 | Blood cell traits latent factor 13 (red cell) | GCST90559255 | 6.90e-03 |
| 11495 | CD160/KLRB1 ratio | GCST90313731 | 6.90e-03 |
| 11496 | Usual side of head for mobile phone use - Right | Electronic device use | UKBB00000890 | 6.90e-03 |
| 11497 | Vitamin D levels | GCST005367 | 6.88e-03 |
| 11498 | ITGAL levels | GCST90469637 | 6.87e-03 |
| 11499 | PLXNB2 levels | GCST90242299 | 6.87e-03 |
| 11500 | IL18 levels | GCST90428411 | 6.87e-03 |
| 11501 | SLAMF1 levels | GCST90274835 | 6.85e-03 |
| 11502 | Blood cell traits latent factor 2 (red cell) | GCST90559244 | 6.83e-03 |
| 11503 | CCL5/RARRES2 ratio | GCST90313704 | 6.82e-03 |
| 11504 | HAVCR2/TNFRSF1B ratio | GCST90315030 | 6.82e-03 |
| 11505 | Lamb liking | GCST90094790 | 6.81e-03 |
| 11506 | CD74/IL18BP ratio | GCST90313892 | 6.80e-03 |
| 11507 | LAYN/VWC2 ratio | GCST90315293 | 6.80e-03 |
| 11508 | CD69/PLXNA4 ratio | GCST90313880 | 6.79e-03 |
| 11509 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T466 | ECGA000466 | 6.79e-03 |
| 11510 | MS-disease / Multiple Sclerosis | FING00000839 | 6.77e-03 |
| 11511 | Depressive episode | Mood [affective] disorders | UKBB00000166 | 6.76e-03 |
| 11512 | Ever highly irritable/argumentative for 2 days | Mental health | UKBB00000219 | 6.75e-03 |
| 11513 | Seropositive rheumatoid arthritis, strict definition | FING00001297 | 6.75e-03 |
| 11514 | PDGFB/VEGFC ratio | GCST90315635 | 6.74e-03 |
| 11515 | FCRL6 levels | GCST90469209 | 6.74e-03 |
| 11516 | CD300E/CD59 ratio | GCST90313794 | 6.74e-03 |
| 11517 | Eosinophil count | GCST90025987 | 6.74e-03 |
| 11518 | Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 8.07_212.10) | GCST90291805 | 6.73e-03 |
| 11519 | Diacylglycerol_42:7_[M+H-H2O]1+ levels | GCST90060226 | 6.72e-03 |
| 11520 | Type of accommodation lived in - A house or bungalow | Household | UKBB00000869 | 6.71e-03 |
| 11521 | Glucose levels | GCST90018735 | 6.70e-03 |
| 11522 | Wheeze or whistling in the chest in last year | Breathing | UKBB00000912 | 6.70e-03 |
| 11523 | Trauma exposure | GCST009982 | 6.69e-03 |
| 11524 | aseg rh volume Cerebellum-White-Matter | GCST90002635 | 6.65e-03 |
| 11525 | Lymphoid leukaemia (controls excluding all cancers) | FING00000741 | 6.64e-03 |
| 11526 | PIK3AP1 levels | GCST90470233 | 6.63e-03 |
| 11527 | Treatment or medication use - metformin (UKB data field 20003_1140884600) | GCST90042245 | 6.62e-03 |
| 11528 | CD300C/CLEC14A ratio | GCST90313786 | 6.61e-03 |
| 11529 | FCGR2B levels | GCST90469201 | 6.59e-03 |
| 11530 | Asthma | GCST90018575 | 6.59e-03 |
| 11531 | ThalamNuclei lh volume VLp | GCST90002734 | 6.56e-03 |
| 11532 | OSCAR/TNFRSF14 ratio | GCST90315588 | 6.56e-03 |
| 11533 | CD27/ICAM3 ratio | GCST90313773 | 6.52e-03 |
| 11534 | EPHA2 levels | GCST90469130 | 6.51e-03 |
| 11535 | Basophil count | GCST90002292 | 6.51e-03 |
| 11536 | F-fruit liking (derived food-liking factor) | GCST90094767 | 6.50e-03 |
| 11537 | AMY2A levels | GCST90468298 | 6.50e-03 |
| 11538 | Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) levels | GCST90200033 | 6.47e-03 |
| 11539 | neutrophil (fraction, minimum, inv-norm transformed) | GCST90475541 | 6.47e-03 |
| 11540 | CANT1/VSIR ratio | GCST90313621 | 6.45e-03 |
| 11541 | ENO2/HCLS1 ratio | GCST90314660 | 6.44e-03 |
| 11542 | Physical activity | GCST90093322 | 6.44e-03 |
| 11543 | Types of physical activity in last 4 weeks - None of the above | Physical activity | UKBB00000872 | 6.43e-03 |
| 11544 | PCDH17/SEMA7A ratio | GCST90315605 | 6.43e-03 |
| 11545 | DKK1/IPCEF1 ratio | GCST90314471 | 6.42e-03 |
| 11546 | GBP1 levels | GCST90469311 | 6.40e-03 |
| 11547 | Destinations on discharge from hospital (recoded) - Usual Place of residence | Summary Administration | UKBB00000167 | 6.36e-03 |
| 11548 | eosinophil (absolute count, maximum, inv-norm transformed) | GCST90475288 | 6.32e-03 |
| 11549 | IFI30 levels | GCST90469509 | 6.32e-03 |
| 11550 | TFF3 levels | GCST90470837 | 6.28e-03 |
| 11551 | Basophil count variance | GCST90565682 | 6.27e-03 |
| 11552 | CTF1/ITGB1BP2 ratio | GCST90314305 | 6.26e-03 |
| 11553 | Generalized epilepsy | FING00000567 | 6.25e-03 |
| 11554 | eGFR in diabetes mellitus (strict) case-control group (minimal adjustment) | GCST90624781 | 6.25e-03 |
| 11555 | Monocyte count | GCST90002341 | 6.24e-03 |
| 11556 | CHMP1A/RHOC ratio | GCST90314053 | 6.24e-03 |
| 11557 | LAT2/YES1 ratio | GCST90315282 | 6.23e-03 |
| 11558 | Eosinophill percentage (UKB data field 30210) | GCST90468069 | 6.23e-03 |
| 11559 | ANXA3/EDAR ratio | GCST90313280 | 6.21e-03 |
| 11560 | TPP1 levels | GCST90470946 | 6.21e-03 |
| 11561 | SKAP1 levels | GCST90470645 | 6.21e-03 |
| 11562 | CDH17/SPINT1 ratio | GCST90313944 | 6.18e-03 |
| 11563 | Acute upper respiratory infections | FING00000034 | 6.18e-03 |
| 11564 | Apple juice liking | GCST90094690 | 6.18e-03 |
| 11565 | Accelerometer-based physical activity measurement (average acceleration) | GCST006099 | 6.18e-03 |
| 11566 | Ratio of omega-6 fatty acids to total fatty acids | GCST90092935 | 6.17e-03 |
| 11567 | CA3/HMBS ratio | GCST90313584 | 6.16e-03 |
| 11568 | Lysophosphatidylcholine (26:0) [sn2] levels | GCST90025428 | 6.15e-03 |
| 11569 | Neurofibromatosis, type 2 | FING00000867 | 6.14e-03 |
| 11570 | Fibrosis and cirrhosis of liver | FING00000543 | 6.13e-03 |
| 11571 | Cancer of kidney and renal pelvis (PheCode 189.1) | GCST90475595 | 6.13e-03 |
| 11572 | Other diseases of upper respiratory tract | FING00001012 | 6.09e-03 |
| 11573 | FGF21 levels | GCST90274788 | 6.08e-03 |
| 11574 | Graves disease, strict definition | FING00000592 | 6.08e-03 |
| 11575 | NPTX2 levels | GCST90470079 | 6.07e-03 |
| 11576 | Bicarbonate (maximum, inv-norm transformed) | GCST90475145 | 6.07e-03 |
| 11577 | Non-ischemic cardiomyopathy | FING00000873 | 6.07e-03 |
| 11578 | AFP levels | GCST90468250 | 6.06e-03 |
| 11579 | MMP1 levels | GCST90469919 | 6.06e-03 |
| 11580 | Chronic sinusitis | FING00000298 | 6.06e-03 |
| 11581 | KLRK1 levels | GCST90469713 | 6.05e-03 |
| 11582 | Eosinophill percentage | Blood count | UKBB00000207 | 6.04e-03 |
| 11583 | ADH4/DCXR ratio | GCST90313190 | 6.02e-03 |
| 11584 | Enthesopathy (PheCode 726.1) | GCST90476239 | 6.02e-03 |
| 11585 | CPXM1/HBEGF ratio | GCST90314219 | 6.02e-03 |
| 11586 | N6,N6-dimethyllysine levels in chronic kidney disease | GCST90257529 | 6.01e-03 |
| 11587 | FCRL1/TREML2 ratio | GCST90314797 | 5.99e-03 |
| 11588 | aparc-Desikan rh volume precuneus | GCST90002825 | 5.98e-03 |
| 11589 | Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive) | GCST90132227 | 5.97e-03 |
| 11590 | CD244/EDAR ratio | GCST90313764 | 5.95e-03 |
| 11591 | Trauma (confirmatory factor analysis Factor 9) | GCST90309343 | 5.95e-03 |
| 11592 | Multi-trait sum score | GCST90270119 | 5.94e-03 |
| 11593 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T462 | ECGA000462 | 5.94e-03 |
| 11594 | NOTCH1/SEMA7A ratio | GCST90315545 | 5.93e-03 |
| 11595 | MEP1B levels | GCST90469888 | 5.93e-03 |
| 11596 | Handedness (chirality/laterality) - Right-handed | Early life factors | UKBB00000303 | 5.93e-03 |
| 11597 | KLRB1/KLRD1 ratio | GCST90315260 | 5.92e-03 |
| 11598 | Ulcerative colitis (strict definition, require KELA, min 2 HDR) | FING00001388 | 5.91e-03 |
| 11599 | Neutrophil percentage of granulocytes | GCST004623 | 5.90e-03 |
| 11600 | Rash and other nonspecific skin eruption (PheCode 687.1) | GCST90476167 | 5.90e-03 |
| 11601 | CRELD2/ERP44 ratio | GCST90314253 | 5.89e-03 |
| 11602 | BCR/CLIP2 ratio | GCST90313486 | 5.87e-03 |
| 11603 | Treatment or medication use - insulin product (UKB data field 20003_1140883066) | GCST90042226 | 5.87e-03 |
| 11604 | PLXNB2/SEMA7A ratio | GCST90315692 | 5.85e-03 |
| 11605 | Basophil count | GCST90002293 | 5.82e-03 |
| 11606 | TMPRSS15 levels | GCST90470892 | 5.81e-03 |
| 11607 | DCXR/SCLY ratio | GCST90314440 | 5.81e-03 |
| 11608 | aseg rh volume VentralDC | GCST90002644 | 5.81e-03 |
| 11609 | GRAP2/SRC ratio | GCST90314989 | 5.81e-03 |
| 11610 | Skin cancer | neoplasms | UKBB00000772 | 5.79e-03 |
| 11611 | CRTAM/KLRD1 ratio | GCST90314277 | 5.78e-03 |
| 11612 | Reason for reducing amount of alcohol drunk - Health precaution | Alcohol | UKBB00000734 | 5.78e-03 |
| 11613 | PTPRR levels | GCST90470386 | 5.78e-03 |
| 11614 | Methods of discharge from hospital (recoded) - Discharged on clinical advice/consent | Summary Administration | UKBB00000466 | 5.77e-03 |
| 11615 | GP1BA/SIAE ratio | GCST90314959 | 5.77e-03 |
| 11616 | FKBP4/WWP2 ratio | GCST90314842 | 5.76e-03 |
| 11617 | CRTAP levels | GCST90468872 | 5.73e-03 |
| 11618 | PSRC1/SORT1 ratio | GCST90315742 | 5.73e-03 |
| 11619 | HSIL lesion of the vulva | FING00000626 | 5.73e-03 |
| 11620 | T1 CAT volume L PlanumPolare | GCST90384086 | 5.72e-03 |
| 11621 | Operative procedures - Total cholecystectomy NEC | Summary Operations | UKBB00000589 | 5.71e-03 |
| 11622 | Cholelithiasis | digestive | UKBB00000131 | 5.68e-03 |
| 11623 | AXIN1/GOPC ratio | GCST90313407 | 5.68e-03 |
| 11624 | GOPC/IRAK4 ratio | GCST90314954 | 5.68e-03 |
| 11625 | TNFSF10 levels | GCST90470917 | 5.67e-03 |
| 11626 | DAB2/GRAP2 ratio | GCST90314364 | 5.65e-03 |
| 11627 | MEP1A levels | GCST90469887 | 5.65e-03 |
| 11628 | Psoriasis | FING00001222 | 5.64e-03 |
| 11629 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T246 | ECGU000246 | 5.64e-03 |
| 11630 | Basophil count | GCST90025997 | 5.63e-03 |
| 11631 | CD200/CLEC4G ratio | GCST90313746 | 5.63e-03 |
| 11632 | AmygNuclei rh volume Whole-amygdala | GCST90002667 | 5.63e-03 |
| 11633 | Wheeze or whistling in the chest in last year (UKB data field 2316) | GCST90043614 | 5.62e-03 |
| 11634 | NADK levels | GCST90469993 | 5.62e-03 |
| 11635 | KIR3DL1 levels | GCST90469687 | 5.62e-03 |
| 11636 | Eosinophill count (UKB data field 30150) | GCST90468068 | 5.61e-03 |
| 11637 | LAYN/TNFRSF4 ratio | GCST90315291 | 5.61e-03 |
| 11638 | Broad bean liking | GCST90094711 | 5.61e-03 |
| 11639 | Body mass index | GCST90278622 | 5.61e-03 |
| 11640 | Peptic ulcer (excl. esophageal) | digestive | UKBB00000639 | 5.59e-03 |
| 11641 | Syncope and collapse | symptoms | UKBB00000801 | 5.59e-03 |
| 11642 | Triacylglycerol_54:3_[M+NH4]1+ levels | GCST90060541 | 5.57e-03 |
| 11643 | ThalamNuclei rh volume CM | GCST90002742 | 5.56e-03 |
| 11644 | aseg rh volume Amygdala | GCST90002642 | 5.53e-03 |
| 11645 | ITIH4 levels | GCST90469651 | 5.53e-03 |
| 11646 | Depression medications | FING00000399 | 5.52e-03 |
| 11647 | Diseases of hair and hair follicles (PheCode 704) | GCST90476209 | 5.51e-03 |
| 11648 | IDP dMRI TBSS ICVF Tapetum L | GCST90004374 | 5.50e-03 |
| 11649 | Ever taken cannabis | Cannabis use | UKBB00000224 | 5.49e-03 |
| 11650 | CC2D1A/CRADD ratio | GCST90313663 | 5.49e-03 |
| 11651 | MAP3K5/ZBTB16 ratio | GCST90315380 | 5.49e-03 |
| 11652 | DARS1/MAP4K5 ratio | GCST90314404 | 5.48e-03 |
| 11653 | Pain in joint (PheCode 745) | GCST90476262 | 5.47e-03 |
| 11654 | Coeliac disease | GCST90468120 | 5.47e-03 |
| 11655 | DTI TBSS MD Cingulum cingulate gyrus L | GCST90384607 | 5.45e-03 |
| 11656 | Asthma, unspecified (mode) | FING00000120 | 5.44e-03 |
| 11657 | CCL25/PRSS27 ratio | GCST90313694 | 5.38e-03 |
| 11658 | CD36 levels | GCST90468627 | 5.36e-03 |
| 11659 | SIGLEC1 levels | GCST90470632 | 5.35e-03 |
| 11660 | Psoriasis vulgaris | FING00001224 | 5.35e-03 |
| 11661 | Alkylphosphatidylcholine (O-34:1) levels | GCST90024925 | 5.35e-03 |
| 11662 | CRKL/MANF ratio | GCST90314269 | 5.34e-03 |
| 11663 | Colon cancer/rectal cancer | GCST90475170 | 5.34e-03 |
| 11664 | IPCEF1/SPARC ratio | GCST90315186 | 5.34e-03 |
| 11665 | rfMRI amplitudes (ICA100 node 7) | GCST90004595 | 5.34e-03 |
| 11666 | F-wine liking (derived food-liking factor) | GCST90094872 | 5.33e-03 |
| 11667 | CA1/CA3 ratio | GCST90313572 | 5.32e-03 |
| 11668 | hemoglobin (minimum, inv-norm transformed) | GCST90475380 | 5.30e-03 |
| 11669 | DOK2/PPP1R2 ratio | GCST90314537 | 5.27e-03 |
| 11670 | NPHS1 levels | GCST90470070 | 5.26e-03 |
| 11671 | Eosinophil count | GCST90002381 | 5.26e-03 |
| 11672 | MAPRE3 levels | GCST90469859 | 5.25e-03 |
| 11673 | PRSS2 levels | GCST90243126 | 5.25e-03 |
| 11674 | Eosinophil percentage of granulocytes | GCST004617 | 5.24e-03 |
| 11675 | Autoimmune diseases excluding thyroid diseases | FING00000132 | 5.22e-03 |
| 11676 | Reimbursement for rheumatic diseases | FING00001247 | 5.20e-03 |
| 11677 | NCK2/VASH1 ratio | GCST90315526 | 5.19e-03 |
| 11678 | CXCL1 levels | GCST90012019 | 5.18e-03 |
| 11679 | APRT/CD63 ratio | GCST90313334 | 5.17e-03 |
| 11680 | NECTIN2/NPDC1 ratio | GCST90315528 | 5.17e-03 |
| 11681 | Eosinophil count | GCST90002298 | 5.17e-03 |
| 11682 | Eosinophil percentage of white cells | GCST004600 | 5.15e-03 |
| 11683 | Early-onset myasthenia gravis | GCST90093465 | 5.12e-03 |
| 11684 | Disorder of skin and subcutaneous tissue NO (PheCode 689) | GCST90476169 | 5.11e-03 |
| 11685 | Epstein-Barr virus ZEBRA antibody levels | GCST90006901 | 5.11e-03 |
| 11686 | Disorders of orbit | FING00000449 | 5.11e-03 |
| 11687 | CEACAM1/GGT1 ratio | GCST90314000 | 5.11e-03 |
| 11688 | hematocrit (minimum, inv-norm transformed) | GCST90475344 | 5.09e-03 |
| 11689 | MAVS/MZT1 ratio | GCST90315391 | 5.08e-03 |
| 11690 | Coffee intake (standard GWA) | GCST90267274 | 5.04e-03 |
| 11691 | Bread type - White | Diet | UKBB00000106 | 5.02e-03 |
| 11692 | Glycated hemoglobin levels | GCST90002244 | 5.01e-03 |
| 11693 | IDP T1 SIENAX peripheral grey normalised volume | GCST90002426 | 5.01e-03 |
| 11694 | Biological Sibling: Asthma | GCST90476372 | 5.00e-03 |
| 11695 | CD163/IL18BP ratio | GCST90313736 | 4.98e-03 |
| 11696 | SCGB3A2 levels | GCST90470543 | 4.96e-03 |
| 11697 | EDAR/IRAK4 ratio | GCST90314579 | 4.95e-03 |
| 11698 | DTI autoptx L2 cgc r tract | GCST90385171 | 4.94e-03 |
| 11699 | CRADD/MAP4K5 ratio | GCST90314240 | 4.94e-03 |
| 11700 | Eosinophil percentage of white cells | GCST90002382 | 4.93e-03 |
| 11701 | CCL24 levels | GCST90468576 | 4.93e-03 |
| 11702 | Treatment/medication code - allopurinol | Medications | UKBB00000839 | 4.93e-03 |
| 11703 | CST3/DEFA1_DEFA1B ratio | GCST90314291 | 4.92e-03 |
| 11704 | ANXA3/ANXA4 ratio | GCST90313278 | 4.90e-03 |
| 11705 | Basophill percentage | Blood count | UKBB00000087 | 4.89e-03 |
| 11706 | TYRP1 levels | GCST90470998 | 4.88e-03 |
| 11707 | PEAR1/TREML2 ratio | GCST90315645 | 4.87e-03 |
| 11708 | Basophil percentage of white cells | GCST90002380 | 4.87e-03 |
| 11709 | Poisoning by antibiotics | injuries & poisonings | UKBB00000653 | 4.87e-03 |
| 11710 | Bipolar and major depression status - No Bipolar or Depression | Mental health | UKBB00000094 | 4.86e-03 |
| 11711 | Alzheimer's disease (late onset) | GCST002245 | 4.85e-03 |
| 11712 | Recent feelings of depression | Depression | UKBB00000737 | 4.84e-03 |
| 11713 | CRADD/EDAR ratio | GCST90314235 | 4.83e-03 |
| 11714 | Linoleic acid to total fatty acids percentage | GCST90502336 | 4.82e-03 |
| 11715 | Acute upper respiratory infections of multiple and unspecified sites | FING00000035 | 4.81e-03 |
| 11716 | Linoleic acid levels | GCST90502310 | 4.80e-03 |
| 11717 | IL17RB levels | GCST90469563 | 4.80e-03 |
| 11718 | Bread type - Wholemeal or wholegrain | Diet | UKBB00000107 | 4.79e-03 |
| 11719 | DTI autoptx L3 ifo r tract | GCST90385206 | 4.79e-03 |
| 11720 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T461 | ECGA000461 | 4.78e-03 |
| 11721 | EXTL1 levels | GCST90469161 | 4.78e-03 |
| 11722 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T468 | ECGA000468 | 4.78e-03 |
| 11723 | Pregnenediol sulfate (C21H34O5S) levels | GCST90199861 | 4.77e-03 |
| 11724 | Other hypertrophic and atrophic conditions (PheCode 701) | GCST90476197 | 4.77e-03 |
| 11725 | Plasma homoarginine levels in chronic kidney disease | GCST90265345 | 4.77e-03 |
| 11726 | X-14626 levels | GCST90243861 | 4.76e-03 |
| 11727 | Principal component-derived dietary pattern 28 | GCST90133033 | 4.76e-03 |
| 11728 | CD79B levels | GCST90468648 | 4.75e-03 |
| 11729 | Total Dihexosylceramide levels | GCST90025821 | 4.75e-03 |
| 11730 | Other hypothyroidism | Disorders of thyroid gland | UKBB00000611 | 4.74e-03 |
| 11731 | Medication use (immunosuppressants) | GCST90018771 | 4.73e-03 |
| 11732 | S100G levels | GCST90470519 | 4.73e-03 |
| 11733 | ADA2/COMP ratio | GCST90313166 | 4.71e-03 |
| 11734 | CPA1/CTRB1 ratio | GCST90314203 | 4.71e-03 |
| 11735 | ATOX1/SPARC ratio | GCST90313375 | 4.71e-03 |
| 11736 | F2R/TMSB10 ratio | GCST90314738 | 4.69e-03 |
| 11737 | ATG4A/NSFL1C ratio | GCST90313368 | 4.68e-03 |
| 11738 | CD8A levels | GCST90468655 | 4.67e-03 |
| 11739 | CXCL5/MESD ratio | GCST90314350 | 4.66e-03 |
| 11740 | Blood cell traits latent factor 8 (white cell) | GCST90559250 | 4.65e-03 |
| 11741 | FADD/PPP1R2 ratio | GCST90314774 | 4.65e-03 |
| 11742 | aparc-a2009s rh area G-postcentral | GCST90003398 | 4.65e-03 |
| 11743 | DCXR/KYNU ratio | GCST90314438 | 4.64e-03 |
| 11744 | CXCL11/ITGB1BP2 ratio | GCST90314335 | 4.63e-03 |
| 11745 | VNN2 levels | GCST90471044 | 4.62e-03 |
| 11746 | HNRNPK/USP8 ratio | GCST90315070 | 4.62e-03 |
| 11747 | CLEC4G/NELL2 ratio | GCST90314122 | 4.59e-03 |
| 11748 | CD160/NCR1 ratio | GCST90313732 | 4.59e-03 |
| 11749 | CRTAM/ICAM3 ratio | GCST90314276 | 4.59e-03 |
| 11750 | Fasciitis (PheCode 728.7) | GCST90476244 | 4.58e-03 |
| 11751 | Other follicular disorders | FING00001050 | 4.58e-03 |
| 11752 | Type of accommodation lived in - A flat, maisonette or apartment | Household | UKBB00000868 | 4.56e-03 |
| 11753 | Feeling lonely | GCST006942 | 4.55e-03 |
| 11754 | Interpolated Year when non-cancer illness first diagnosed | Medical conditions | UKBB00000371 | 4.54e-03 |
| 11755 | BCAM/LGALS4 ratio | GCST90313473 | 4.53e-03 |
| 11756 | CASP3/MESD ratio | GCST90313636 | 4.52e-03 |
| 11757 | FOLR2 levels | GCST90469260 | 4.52e-03 |
| 11758 | Hypothyroidism NOS | endocrine/metabolic | UKBB00000336 | 4.50e-03 |
| 11759 | Blood glucose levels | GCST90025986 | 4.50e-03 |
| 11760 | FCRL5 levels | GCST90469208 | 4.49e-03 |
| 11761 | VEGFC/ZBTB16 ratio | GCST90315946 | 4.48e-03 |
| 11762 | IRAG2/TBC1D23 ratio | GCST90315191 | 4.44e-03 |
| 11763 | DTI TBSS L1 Body of corpus callosum | GCST90384431 | 4.44e-03 |
| 11764 | First line medication for Crohn's disease | FING00000544 | 4.43e-03 |
| 11765 | Asthma-related infections | FING00000118 | 4.43e-03 |
| 11766 | Crohn's disease of small intestine | FING00000369 | 4.43e-03 |
| 11767 | DECR1/STX8 ratio | GCST90314452 | 4.43e-03 |
| 11768 | Other disorders of skin and subcutaneous tissue, not elsewhere classified | FING00001036 | 4.42e-03 |
| 11769 | Eosinophil count | GCST004606 | 4.41e-03 |
| 11770 | Oranges liking | GCST90094807 | 4.40e-03 |
| 11771 | Seen a psychiatrist for nerves, anxiety, tension or depression | Mental health | UKBB00000764 | 4.39e-03 |
| 11772 | Other and unspecified tonsillitis | FING00000954 | 4.39e-03 |
| 11773 | T1 FreeSurfer aseg lhCerebralWhiteMatterVol | GCST90384185 | 4.39e-03 |
| 11774 | Other eye problems | Eyesight | UKBB00000610 | 4.38e-03 |
| 11775 | NUCB2/RSPO3 ratio | GCST90315575 | 4.36e-03 |
| 11776 | SPRY2/YTHDF3 ratio | GCST90315881 | 4.35e-03 |
| 11777 | MBL2 levels | GCST90469868 | 4.35e-03 |
| 11778 | IDP dMRI TBSS ISOVF Superior cerebellar peduncle L | GCST90004490 | 4.34e-03 |
| 11779 | T1 CAT volume L VIIIa | GCST90384127 | 4.34e-03 |
| 11780 | Asthma | GCST90475259 | 4.33e-03 |
| 11781 | JCHAIN levels | GCST90469661 | 4.33e-03 |
| 11782 | lymphocyte (absolute count, minimum, inv-norm transformed) | GCST90475429 | 4.33e-03 |
| 11783 | CD300E levels | GCST90468621 | 4.32e-03 |
| 11784 | CD63/EDAR ratio | GCST90313864 | 4.30e-03 |
| 11785 | Physical activity (Total log acceleration 6pm-8pm) | GCST90061418 | 4.30e-03 |
| 11786 | FOXO3/MAP3K5 ratio | GCST90314880 | 4.28e-03 |
| 11787 | Lichen ruber planus, wide definition including periferal and oral lichen planus | FING00000722 | 4.27e-03 |
| 11788 | Type 2 diabetes | endocrine/metabolic | UKBB00000867 | 4.27e-03 |
| 11789 | Soy sauce liking | GCST90094844 | 4.25e-03 |
| 11790 | PRSS8 levels | GCST90470345 | 4.24e-03 |
| 11791 | Hashimoto thyroiditis | GCST90018635 | 4.24e-03 |
| 11792 | ACHE levels | GCST90468199 | 4.23e-03 |
| 11793 | S100A11/S100A12 ratio | GCST90315798 | 4.23e-03 |
| 11794 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T460 | ECGA000460 | 4.22e-03 |
| 11795 | Spondylopathies (FG) | FING00001326 | 4.22e-03 |
| 11796 | AHSG levels | GCST90468263 | 4.19e-03 |
| 11797 | lymphocyte (fraction, minimum, inv-norm transformed) | GCST90475438 | 4.19e-03 |
| 11798 | Duration walking for pleasure | Physical activity | UKBB00000203 | 4.18e-03 |
| 11799 | Bread type: Wholemeal/wholegrain vs white and brown (UKB data field 1448) | GCST90132968 | 4.16e-03 |
| 11800 | Actinic keratosis | FING00000013 | 4.15e-03 |
| 11801 | CNDP1/F9 ratio | GCST90314147 | 4.14e-03 |
| 11802 | NELL2/SEZ6L ratio | GCST90315536 | 4.14e-03 |
| 11803 | neutrophil (fraction, mean, inv-norm transformed) | GCST90475538 | 4.13e-03 |
| 11804 | ITGB6 levels | GCST90469646 | 4.13e-03 |
| 11805 | ARNT levels | GCST90468367 | 4.12e-03 |
| 11806 | N6-methyllysine levels in chronic kidney disease | GCST90257530 | 4.12e-03 |
| 11807 | FCRL6/KLRD1 ratio | GCST90314807 | 4.12e-03 |
| 11808 | Number in household | Household | UKBB00000530 | 4.12e-03 |
| 11809 | Depression | GCST003769 | 4.11e-03 |
| 11810 | KLK8 levels | GCST90425492 | 4.11e-03 |
| 11811 | IL2RA/NCR1 ratio | GCST90315161 | 4.10e-03 |
| 11812 | MYBPC1 levels | GCST90469969 | 4.08e-03 |
| 11813 | CLEC1B/HBEGF ratio | GCST90314092 | 4.08e-03 |
| 11814 | Treatment speciality of consultant (recoded) - Dermatology | Summary Administration | UKBB00000830 | 4.07e-03 |
| 11815 | Clonal haematopoiesis of indeterminate potential (ASXL1 mutation) | GCST90165259 | 4.06e-03 |
| 11816 | PGLYRP1 levels | GCST90470219 | 4.06e-03 |
| 11817 | Fluid intelligence score | Fluid intelligence / reasoning | UKBB00000250 | 4.05e-03 |
| 11818 | MICB_MICA/TEK ratio | GCST90315446 | 4.05e-03 |
| 11819 | ZNF830 levels | GCST90471102 | 4.04e-03 |
| 11820 | Loneliness (standard GWA) | GCST90267288 | 4.04e-03 |
| 11821 | BCR/FOXO1 ratio | GCST90313490 | 4.04e-03 |
| 11822 | Urticaria | FING00001408 | 4.03e-03 |
| 11823 | Urine N-acetyl-cadaverine levels in chronic kidney disease | GCST90265541 | 4.02e-03 |
| 11824 | Carnitine levels | GCST90199621 | 4.00e-03 |
| 11825 | Hypothyroidism | endocrine/metabolic | UKBB00000335 | 4.00e-03 |
| 11826 | MAX/TDRKH ratio | GCST90315406 | 4.00e-03 |
| 11827 | CA9/CBLIF ratio | GCST90313595 | 3.99e-03 |
| 11828 | Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers) | FING00000764 | 3.98e-03 |
| 11829 | ABHD14B/APRT ratio | GCST90313137 | 3.96e-03 |
| 11830 | Basal cell carcinoma | GCST90468114 | 3.95e-03 |
| 11831 | DAB2/VASH1 ratio | GCST90314369 | 3.92e-03 |
| 11832 | chloride (mean, inv-norm transformed) | GCST90475194 | 3.91e-03 |
| 11833 | Number of days/week walked 10+ minutes | Physical activity | UKBB00000535 | 3.91e-03 |
| 11834 | CCN2/TPP1 ratio | GCST90313718 | 3.91e-03 |
| 11835 | DKK1/PDGFA ratio | GCST90314475 | 3.90e-03 |
| 11836 | Varicose veins of lower extremity, symptomtic (PheCode 454.11) | GCST90476014 | 3.89e-03 |
| 11837 | aparc-a2009s lh area S-precentral-sup-part | GCST90003365 | 3.88e-03 |
| 11838 | DTI TBSS L3 Genu of corpus callosum | GCST90384526 | 3.86e-03 |
| 11839 | AmygNuclei lh volume Whole-amygdala | GCST90002657 | 3.86e-03 |
| 11840 | Cholelithiasis | GCST90018599 | 3.85e-03 |
| 11841 | Mouth/teeth dental problems - Mouth ulcers | Mouth | UKBB00000488 | 3.85e-03 |
| 11842 | DIABLO/DOK2 ratio | GCST90314464 | 3.85e-03 |
| 11843 | Prescriptions - thyroid hormone | hormone | UKBB00000705 | 3.83e-03 |
| 11844 | Prescriptions - levothyroxine | thyroid hormone | UKBB00000687 | 3.83e-03 |
| 11845 | Glucose levels (UKB data field 23470) | GCST90269567 | 3.81e-03 |
| 11846 | CXCL5/PPIB ratio | GCST90314352 | 3.81e-03 |
| 11847 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502074 | 3.81e-03 |
| 11848 | HSBP1 levels | GCST90469481 | 3.80e-03 |
| 11849 | Number of operations, self-reported | Operations | UKBB00000539 | 3.78e-03 |
| 11850 | KLK13 levels | GCST90469699 | 3.78e-03 |
| 11851 | MRPL33 levels | GCST90617986 | 3.76e-03 |
| 11852 | Ever suffered mental distress preventing usual activities | Mental distress | UKBB00000223 | 3.74e-03 |
| 11853 | CEP43/USP8 ratio | GCST90314022 | 3.73e-03 |
| 11854 | ART3/GPC1 ratio | GCST90313361 | 3.73e-03 |
| 11855 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T465 | ECGA000465 | 3.73e-03 |
| 11856 | Thyrotoxicosis with toxic multinodular goitre | FING00001362 | 3.72e-03 |
| 11857 | GYS1/PPP1R2 ratio | GCST90315001 | 3.71e-03 |
| 11858 | CD22/TCL1A ratio | GCST90313760 | 3.71e-03 |
| 11859 | Non-insulin-dependent diabetes mellitus | Diabetes mellitus | UKBB00000524 | 3.70e-03 |
| 11860 | CD101 levels | GCST90468596 | 3.70e-03 |
| 11861 | DTI autoptx L1 atr r tract | GCST90385142 | 3.69e-03 |
| 11862 | Iridocyclitis | FING00000696 | 3.67e-03 |
| 11863 | BCR/PLXNA4 ratio | GCST90313497 | 3.67e-03 |
| 11864 | Red meat liking | GCST90094819 | 3.66e-03 |
| 11865 | Plateletcrit | GCST004607 | 3.65e-03 |
| 11866 | Platelet distribution width | GCST90002401 | 3.64e-03 |
| 11867 | IDP dMRI TBSS OD Posterior corona radiata L | GCST90004429 | 3.64e-03 |
| 11868 | Oral glucose tolerance test-2h | GCST90297790 | 3.63e-03 |
| 11869 | CD5 levels | GCST90468641 | 3.62e-03 |
| 11870 | GNLY levels | GCST90469372 | 3.62e-03 |
| 11871 | Fasting plasma glucose | GCST90566420 | 3.62e-03 |
| 11872 | Conduction disorders | FING00000324 | 3.61e-03 |
| 11873 | ALCAM/ICAM3 ratio | GCST90313237 | 3.61e-03 |
| 11874 | Principal component-derived dietary pattern 24 | GCST90133029 | 3.58e-03 |
| 11875 | CD27 levels | GCST90468615 | 3.57e-03 |
| 11876 | Treatment/medication code - levothyroxine sodium | Medications | UKBB00000849 | 3.56e-03 |
| 11877 | STX6 levels | GCST90470774 | 3.55e-03 |
| 11878 | ULBP2 levels | GCST90471008 | 3.55e-03 |
| 11879 | Platelet distribution width | GCST004616 | 3.54e-03 |
| 11880 | CD79B/TNFRSF4 ratio | GCST90313903 | 3.54e-03 |
| 11881 | DIABLO/GRAP2 ratio | GCST90314466 | 3.53e-03 |
| 11882 | Diabetes mellitus | endocrine/metabolic | UKBB00000169 | 3.53e-03 |
| 11883 | Mean sphered cell volume | Blood count | UKBB00000452 | 3.52e-03 |
| 11884 | PIK3AP1/PSMG3 ratio | GCST90315651 | 3.51e-03 |
| 11885 | PPME1/PSMD9 ratio | GCST90315705 | 3.50e-03 |
| 11886 | CD163/ICAM1 ratio | GCST90313735 | 3.50e-03 |
| 11887 | Rheumatoid arthritis | GCST90132224 | 3.50e-03 |
| 11888 | Non-cancer illness code, self-reported - hypothyroidism/myxoedema | Medical conditions | UKBB00000518 | 3.49e-03 |
| 11889 | IL18 levels | GCST90469567 | 3.49e-03 |
| 11890 | SRPK2/VASH1 ratio | GCST90315886 | 3.49e-03 |
| 11891 | Irritable bowel syndrome mixed subtype | GCST90243959 | 3.48e-03 |
| 11892 | DTI TBSS MD Anterior limb of internal capsule R | GCST90384588 | 3.48e-03 |
| 11893 | Autoimmune diseases | FING00000131 | 3.47e-03 |
| 11894 | CRELD2/F2R ratio | GCST90314254 | 3.46e-03 |
| 11895 | CLEC4G/LGALS4 ratio | GCST90314120 | 3.46e-03 |
| 11896 | IL6 levels | GCST90469604 | 3.46e-03 |
| 11897 | Childhood asthma (age<16) (more control exclusions) | FING00000270 | 3.46e-03 |
| 11898 | Cucumber liking | GCST90094749 | 3.45e-03 |
| 11899 | LDLR levels | GCST90469750 | 3.42e-03 |
| 11900 | HLA-A levels | GCST90469457 | 3.40e-03 |
| 11901 | CEP43/MPHOSPH8 ratio | GCST90314019 | 3.39e-03 |
| 11902 | TCL1A levels | GCST90470817 | 3.39e-03 |
| 11903 | Principal component-derived dietary pattern 21 | GCST90133026 | 3.37e-03 |
| 11904 | EDAR/F2R ratio | GCST90314577 | 3.37e-03 |
| 11905 | CD58/IFNGR1 ratio | GCST90313849 | 3.36e-03 |
| 11906 | aparc-Desikan rh area postcentral | GCST90003128 | 3.35e-03 |
| 11907 | eosinophil (fraction, mean, inv-norm transformed) | GCST90475300 | 3.30e-03 |
| 11908 | Social and economic stability (confirmatory factor analysis Factor 15) | GCST90309349 | 3.30e-03 |
| 11909 | IDP dMRI TBSS OD Posterior limb of internal capsule L | GCST90004421 | 3.30e-03 |
| 11910 | CDKN1A/TACC3 ratio | GCST90313975 | 3.29e-03 |
| 11911 | ACE2/MME ratio | GCST90313154 | 3.29e-03 |
| 11912 | lymphocyte (fraction, maximum, inv-norm transformed) | GCST90475432 | 3.29e-03 |
| 11913 | DBI/EDAR ratio | GCST90314408 | 3.29e-03 |
| 11914 | Other maternal disorders predominantly related to pregnancy | FING00001069 | 3.28e-03 |
| 11915 | Mean sphered cell volume (UKB data field 30270) | GCST90468089 | 3.28e-03 |
| 11916 | Doctor diagnosed hayfever or allergic rhinitis | Medical information | UKBB00000192 | 3.28e-03 |
| 11917 | aparc-a2009s lh volume S-precentral-sup-part | GCST90002993 | 3.27e-03 |
| 11918 | F2R/SPINT2 ratio | GCST90314737 | 3.25e-03 |
| 11919 | Placental weight (paternal genotype, adjusted for sex and gestational age) | GCST90275191 | 3.21e-03 |
| 11920 | REST UKBBICA NODEamps25 0005 | GCST90385488 | 3.21e-03 |
| 11921 | DTI TBSS MD Posterior limb of internal capsule L | GCST90384591 | 3.19e-03 |
| 11922 | Pollinosis | GCST90018683 | 3.19e-03 |
| 11923 | EPHB6/LAYN ratio | GCST90314681 | 3.18e-03 |
| 11924 | SCARF1/TNFRSF14 ratio | GCST90315812 | 3.18e-03 |
| 11925 | Lifespan | GCST90551885 | 3.18e-03 |
| 11926 | MAVS/MYO9B ratio | GCST90315390 | 3.17e-03 |
| 11927 | BANK1/FOXO1 ratio | GCST90313456 | 3.16e-03 |
| 11928 | CDH17/PTPRM ratio | GCST90313943 | 3.15e-03 |
| 11929 | Asthma (only as main-diagnosis) (more control exclusions) | FING00000114 | 3.15e-03 |
| 11930 | ITGB1BP2/TIA1 ratio | GCST90315222 | 3.14e-03 |
| 11931 | Eosinophil count | GCST90002299 | 3.13e-03 |
| 11932 | Salad / raw vegetable intake | Diet | UKBB00000761 | 3.13e-03 |
| 11933 | Frontotemporal dementia | FING00000560 | 3.12e-03 |
| 11934 | EFNA4/VWC2 ratio | GCST90314607 | 3.12e-03 |
| 11935 | DEFA1_DEFA1B/PTGDS ratio | GCST90314455 | 3.11e-03 |
| 11936 | CD300LF levels | GCST90468622 | 3.11e-03 |
| 11937 | LGALS4 levels | GCST90469762 | 3.11e-03 |
| 11938 | ICAM3/NOTCH1 ratio | GCST90315122 | 3.10e-03 |
| 11939 | CLEC4D/CLEC6A ratio | GCST90314109 | 3.10e-03 |
| 11940 | IL15/IL18BP ratio | GCST90315148 | 3.10e-03 |
| 11941 | IL27 levels | GCST90469060 | 3.08e-03 |
| 11942 | Cheesecake liking | GCST90094730 | 3.07e-03 |
| 11943 | Malignant melanoma of skin, excluding all cancers (controls excluding all cancers) | FING00000749 | 3.06e-03 |
| 11944 | CD300C/HAVCR2 ratio | GCST90313789 | 3.04e-03 |
| 11945 | Frequency of unenthusiasm / disinterest in last 2 weeks | Mental health | UKBB00000270 | 3.03e-03 |
| 11946 | AGXT/GSTA1 ratio | GCST90313206 | 3.03e-03 |
| 11947 | Time spent watching television (TV) | Physical activity | UKBB00000821 | 3.02e-03 |
| 11948 | AK1/PEBP1 ratio | GCST90313225 | 3.01e-03 |
| 11949 | CCL3 levels | GCST90468582 | 2.99e-03 |
| 11950 | Positional arithmetic | Fluid intelligence / reasoning | UKBB00000654 | 2.99e-03 |
| 11951 | Platelet distribution width (UKB data field 30110) | GCST90468097 | 2.99e-03 |
| 11952 | Chronic nephritic syndrome | FING00000295 | 2.98e-03 |
| 11953 | GYS1/TIA1 ratio | GCST90315004 | 2.98e-03 |
| 11954 | DKK1/ZBTB16 ratio | GCST90314486 | 2.97e-03 |
| 11955 | Burger liking | GCST90094715 | 2.96e-03 |
| 11956 | Bifidobacterium kashiwanohense abundance in stool | GCST90032226 | 2.96e-03 |
| 11957 | lymphocyte (fraction, mean, inv-norm transformed) | GCST90475435 | 2.95e-03 |
| 11958 | Spicy food liking | GCST90094846 | 2.92e-03 |
| 11959 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T463 | ECGA000463 | 2.92e-03 |
| 11960 | IDP dMRI TBSS ISOVF Genu of corpus callosum | GCST90004479 | 2.90e-03 |
| 11961 | Excessive sweating | GCST006090 | 2.89e-03 |
| 11962 | Type 1 diabetes | GCST90013791 | 2.89e-03 |
| 11963 | HGF levels | GCST90469449 | 2.88e-03 |
| 11964 | Irritable bowel syndrome | GCST90243958 | 2.87e-03 |
| 11965 | CEACAM8 levels | GCST90468698 | 2.85e-03 |
| 11966 | GZMH/KLRD1 ratio | GCST90315016 | 2.84e-03 |
| 11967 | Allergy/adverse effect of penicillin | injuries & poisonings | UKBB00000028 | 2.84e-03 |
| 11968 | Noninfectious disorders of lymphatic channels (PheCode 450) | GCST90476002 | 2.83e-03 |
| 11969 | Systemic lupus erythematosus | GCST90011866 | 2.83e-03 |
| 11970 | CD1C/CD207 ratio | GCST90313745 | 2.83e-03 |
| 11971 | Basophil count | GCST90002379 | 2.82e-03 |
| 11972 | CLEC4G/KDR ratio | GCST90314118 | 2.82e-03 |
| 11973 | WFIKKN2 levels | GCST90471077 | 2.81e-03 |
| 11974 | EDAR/TXNDC5 ratio | GCST90314593 | 2.80e-03 |
| 11975 | Asthma/COPD (KELA code 203) | FING00000121 | 2.80e-03 |
| 11976 | BA-exvivo rh area BA4a | GCST90003225 | 2.80e-03 |
| 11977 | FCER2 levels | GCST90469199 | 2.80e-03 |
| 11978 | CCL2 levels | GCST90468581 | 2.79e-03 |
| 11979 | eosinophil (fraction, maximum, inv-norm transformed) | GCST90475297 | 2.78e-03 |
| 11980 | CLEC11A levels | GCST90468764 | 2.77e-03 |
| 11981 | Alanine levels | GCST90092806 | 2.77e-03 |
| 11982 | HBEGF/PDGFA ratio | GCST90315033 | 2.76e-03 |
| 11983 | Glycated haemoglobin HbA1c levels (UKB data field 30750) | GCST90468072 | 2.76e-03 |
| 11984 | CEACAM6 levels | GCST90468697 | 2.75e-03 |
| 11985 | Plasma X-24947 levels in chronic kidney disease | GCST90266816 | 2.75e-03 |
| 11986 | CLSTN2 levels | GCST90468789 | 2.75e-03 |
| 11987 | Treatment/medication code - ventolin 100micrograms inhaler | Medications | UKBB00000860 | 2.74e-03 |
| 11988 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T461 | ECGU000461 | 2.74e-03 |
| 11989 | Monocyte count | GCST90018747 | 2.73e-03 |
| 11990 | CD209 levels | GCST90468608 | 2.69e-03 |
| 11991 | Soya milk liking | GCST90094845 | 2.67e-03 |
| 11992 | Birth weight known - Yes - pounds and ounces | Early life factors | UKBB00000097 | 2.66e-03 |
| 11993 | GPKOW levels | GCST90469392 | 2.65e-03 |
| 11994 | CD300E/EFNA4 ratio | GCST90313797 | 2.63e-03 |
| 11995 | Viral warts & HPV (PheCode 78) | GCST90475555 | 2.62e-03 |
| 11996 | CLEC4G/MERTK ratio | GCST90314121 | 2.61e-03 |
| 11997 | Birth weight known - No | Early life factors | UKBB00000096 | 2.61e-03 |
| 11998 | Plateletcrit | GCST90002400 | 2.61e-03 |
| 11999 | MGLL/STK4 ratio | GCST90315443 | 2.60e-03 |
| 12000 | Crohn's disease NAS | FING00000367 | 2.60e-03 |